All Stories

  1. Association between sleep disturbances and suicidal thoughts in a large sample of university students
  2. A large-scale study of Chronic Sleep Disorders in Psychiatric Inpatients: prevalence, hospitalization burden, restraint use, and comorbidities
  3. A study on electroretinography as a biomarker for seasonal vulnerability in depression
  4. Nonrestorative Sleep: A simple question with major consequences - A call to integrate sleep health in preventive medicine
  5. Napping and psychiatric disorders: a systematic review.
  6. Proposition of a new, minimally-invasive, software smartphone device to predict sleep apnea and its severity
  7. Association between sleep complaints and quality of life and the mediating role of substance use disorders: results from a nationally representative sample
  8. Sleep and Dreams as Reflected by Science Fiction Literature and Films—Anything to Learn From?
  9. Burning the diagnosis: When burn-out masks psychiatric and sleep disorders
  10. Investigating circadian patterns in electrochemical skin Conductance: A year-long retrospective analysis using home-based devices
  11. Light therapy for bipolar disorders: Clinical recommendations from the international society for bipolar disorders (ISBD) Chronobiology and Chronotherapy Task Force
  12. Management of Insomnia Complaints by Non‐Sleep Specialist Physicians: A French DELPHI Consensus
  13. Screening and evaluating seasonal affective disorder: a systematic review of available assessment tools
  14. Validation of the French version of the Insomnia Severity Index in a population with psychiatric disorders and sleep complaints
  15. Innovative Digital Cognitive Behavioral Treatment for Insomnia Disorder in Adults (dCBT-i): Framework Development
  16. Evaluation of a Contactless Sleep Monitoring Device for Sleep Stage Detection against Home Polysomnography in a Healthy Population
  17. Evaluation of a Contactless Sleep Monitoring Device for Sleep Stage Detection against Home Polysomnography in a Healthy Population (Preprint)
  18. Chronobiology of Mood Disorders: The Role of the Biological Clock in Depression and Bipolar Disorder
  19. Increased sleep duration and emotional regulation in patients with major depressive episodes
  20. L’absence d’examen physique par le psychiatre n’est pas éthique
  21. Acceptability of Health Information Technology by Healthcare Professionals: where are we now and how can we fill the gap? (Preprint)
  22. Pupillary response to blue light as a biomarker of seasonal pattern in Major Depressive Episode: A clinical study using pupillometry
  23. Cerebral blood flow in attention deficit hyperactivity disorder: A systematic review
  24. Sex differences in insomnia and hypersomnia complaints during major depressive episode: Results from a national sample
  25. Innovative Digital Cognitive Behavioral Treatment for Insomnia Disorder in Adults (dCBT-i): Framework Development (Preprint)
  26. States of consciousness and interoceptive hypersensibility: A study in patients with insomnia disorder
  27. Insomnia and circadian rhythms dysregulation in people who have attempted suicide: correlations with markers of inflammation and suicidal lethality
  28. The electroretinography to identify biomarkers of idiopathic hypersomnia and narcolepsy type 1
  29. Study of the different sleep disturbances during the prodromal phase of depression and mania in bipolar disorders
  30. Comparative study of sleep and circadian rhythms in patients presenting unipolar or bipolar major depressive episodes
  31. Lower risk of hospitalisation for depression following hospitalisation for COVID-19 versus for another reason
  32. Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
  33. Exploring seasonality in catatonia diagnosis: Evidence from a large-scale population study
  34. Content analysis of insomnia questionnaires: A step to better evaluate the complex and multifaceted construct of insomnia disorder
  35. Major depressive episode with insomnia and excessive daytime sleepiness: A more homogeneous and severe subtype of depression
  36. Predictors of cognitive behavioral therapy for insomnia (CBT-I) effects in insomnia with major depressive episode
  37. The nightmare severity index (NSI): A short new multidimensional tool for assessing nightmares
  38. Insomnia in neurological disorders: Prevalence, mechanisms, impact and treatment approaches
  39. Dark skies before the storm: The Chronos syndrome
  40. Efficacy of melatonin and ramelteon for the acute and long‐term management of insomnia disorder in adults: A systematic review and meta‐analysis
  41. How are you dreaming? A very simple question to screen for suicide risk
  42. Validation of a data collection set for the psychiatric, addiction, sleep and chronobiological assessments of patients with depression: A Delphi study for the SoPsy-depression French national cohort
  43. Sleep Deprivation and Insomnia in Adolescence: Implications for Mental Health
  44. Emotional Exhaustion, a Proxy for Burnout, Is Associated with Sleep Health in French Healthcare Workers without Anxiety or Depressive Symptoms: A Cross-Sectional Study
  45. Continuous positive airway pressure as an accurate marker for non‐24‐hour sleep–wake rhythm disorder
  46. Sleep quality of medical students and relationships with academic performances
  47. Systematic Item Content and Overlap Analysis of Self-Reported Multiple Sleep Disorder Screening Questionnaires in Adults
  48. Sleep Complaints Among Adults With Major Depressive Episode Are Associated With Increased Risk of Incident Psychiatric Disorders
  49. A comparison of four methods to estimate dim light melatonin onset: a repeatability and agreement study
  50. Bad Dreams and Nightmares Preceding Suicidal Behaviors
  51. A cross‐sectional study: Nitrous oxide abuse in Parisian medical students
  52. Factors associated with insomnia symptoms: A cross‐sectional study during a Covid‐19 fully restrictive lockdown
  53. The “GHU-Checkist”: Validity and acceptability of a 17-words checklist for rapid screening of depressive symptoms and anxiety
  54. Sleep Markers in Psychiatry: Do Insomnia and Disturbed Sleep Play as Markers of Disrupted Neuroplasticity in Mood Disorders? A Proposed Model
  55. Gender-related associations between psychiatric disorders and alcohol use disorder: Findings from the french “Mental health in the general population” survey
  56. Association between polarity of first episode and solar insolation in bipolar I disorder
  57. A Systematic Review of Sleep–Wake Disorder Diagnostic Criteria Reliability Studies
  58. How Can Digital Mental Health Enhance Psychiatry?
  59. The melanopsin-mediated pupil response is reduced in idiopathic hypersomnia with long sleep time
  60. Seasonal changes and decrease of suicides and suicide attempts in France over the last 10 years
  61. Insomnia evaluation and treatment during peripartum: a joint position paper from the European Insomnia Network task force “Sleep and Women,” the Italian Marcè Society and international experts task force for perinatal mental health
  62. Neurologic Outcomes of Survivors of COVID-19–Associated Acute Respiratory Distress Syndrome Requiring Intubation
  63. Melatonin does not reduce mortality in adult hospitalized patients with COVID-19: a multicenter retrospective observational study
  64. Multi-Level Processes and Retina–Brain Pathways of Photic Regulation of Mood
  65. A study of nightmares in patients with psychiatric disorders
  66. Sleep disturbances in early clinical stages of psychotic and bipolar disorders: A meta-analysis
  67. Impact of meteorological factors on alcohol use disorders: A study in emergency departments
  68. Tobacco-induced sleep disturbances: A systematic review and meta-analysis
  69. Seasonal Changes and Decrease of Suicides and Suicide Attempts in France Over the Last 10 Years”.
  70. Investigating racing thoughts in insomnia: A neglected piece of the mood-sleep puzzle?
  71. Why do sleep disorders belong to mental disorder classifications? A network analysis of the “Sleep-Wake Disorders” section of the DSM-5
  72. Sleep and circadian rhythm characteristics in individuals from the general population during the French COVID‐19 full lockdown
  73. Polysomnography in seasonal affective disorder: A systematic review and meta-analysis
  74. Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder
  75. Efficacy and safety of topiramate for reducing impulsivity: A transdiagnostic systematic review and meta‐analysis of a common clinical use
  76. A systematic analysis of ICSD-3 diagnostic criteria and proposal for further structured iteration
  77. Symptom network analysis of the sleep disorders diagnostic criteria based on the clinical text of the ICSD‐3
  78. Correction to: Religiosity and prevalence of suicide, psychiatric disorders and psychotic symptoms in the French general population
  79. International Expert Opinions and Recommendations on the Use of Melatonin in the Treatment of Insomnia and Circadian Sleep Disturbances in Adult Neuropsychiatric Disorders
  80. The Effects of Transcranial Electrical Stimulation of the Brain on Sleep: A Systematic Review
  81. Validity and Usage of the Seasonal Pattern Assessment Questionnaire (SPAQ) in a French Population of Patients with Depression, Bipolar Disorders and Controls
  82. Early Life Stress and Chronobiological Rhythms Desynchronization
  83. Use of immediate release melatonin in psychiatry: BMI impacts the daily-dose
  84. Des gènes circadiens à la sémiologie psychiatrique
  85. Biological rhythms and chronotherapeutics in depression
  86. Religiosity and prevalence of suicide, psychiatric disorders and psychotic symptoms in the French general population
  87. Chloroquine-Induced First-Episode Psychosis in a Patient Self-medicated for COVID-19
  88. Predictors of Suicidal Ideation and Preparatory Behaviors in Individuals With Bipolar Disorder
  89. Insomnia, sleep loss and circadian sleep disturbances in mood disorders: a pathway toward neurodegeneration and neuroprogression? A theoretical review
  90. Sadness and the continuum from well-being to depressive disorder: Findings from a representative US population sample
  91. Nightmares in Patients with Major Depressive Disorder, Bipolar Disorder, and Psychotic Disorders: A Systematic Review
  92. Misperception of sleep in bipolar disorder: an exploratory study using questionnaire versus actigraphy
  93. Lightening depression
  94. Recent Stressful Life Events in Euthymic Major Depressive Disorder Patients: Sociodemographic and Clinical Characteristics
  95. Depression with and without a history of psychotic symptoms in the general population: sociodemographic and clinical characteristics
  96. Measuring circadian function in bipolar disorders: Empirical and conceptual review of physiological, actigraphic, and self‐report approaches
  97. A Latent Class Analysis of Manic and Psychotic Symptoms
  98. The Light of Hope in Antidepressant Strategies
  99. Activity, cognition, and emotion: Three dimensional pillars of the natural presentations of mood disorders enriched by the “sleep” fourth dimension (ACES)
  100. Conséquences psychopathologiques du confinement
  101. Psychological Support System for Hospital Workers During the Covid-19 Outbreak: Rapid Design and Implementation of the Covid-Psy Hotline
  102. Efficacy of tDCS for bipolar depression in a patient with spinocerebellar ataxia: A case report
  103. Shorter and longer durations of sleep are associated with an increased twelve-month prevalence of psychiatric and substance use disorders: Findings from a nationally representative survey of US adults (NESARC-III)
  104. Sleep complaints are associated with increased suicide risk independently of psychiatric disorders: results from a national 3-year prospective study
  105. Standardized Patients or Conventional Lecture for Teaching Communication Skills to Undergraduate Medical Students: A Randomized Controlled Study
  106. Intérêts d’un atelier de simulation avec des patients standardisés pour la formation à l’examen du risque suicidaire
  107. Alterations in circadian rhythms following alcohol use: A systematic review
  108. Inhibition of Phytosterol Biosynthesis by Azasterols
  109. Association between coffee, tobacco, and alcohol daily consumption and sleep/wake cycle: an actigraphy study in euthymic patients with bipolar disorders
  110. Hopelessness and its correlates with clinical outcomes in an outpatient setting
  111. Alexithymia as a possible specifier of adverse outcomes: Clinical correlates in euthymic unipolar individuals
  112. Management of insomnia in alcohol use disorder
  113. Functional Motor Symptoms in Parkinson’s Disease and Functional Parkinsonism: A Systematic Review
  114. Light therapy with boxes or glasses to counteract effects of acute sleep deprivation
  115. Efficacy of light therapy versus antidepressant drugs, and of the combination versus monotherapy, in major depressive episodes: A systematic review and meta-analysis
  116. The chronotherapeutic treatment of bipolar disorders: A systematic review and practice recommendations from the ISBD task force on chronotherapy and chronobiology
  117. Eveningness and poor sleep quality contribute to depressive residual symptoms and behavioral inhibition in patients with bipolar disorder
  118. The use of melatonin in adult psychiatric disorders: Expert recommendations by the French institute of medical research on sleep (SFRMS)
  119. Alcohol Use Disorder Is Differently Associated With Psychotic Symptoms According To Underlying Psychiatric Disorders: A General Population Study
  120. An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes
  121. Plastic Adaptation to Pathology in Psychiatry: Are Patients with Psychiatric Disorders Pathological Experts?
  122. Metabolic engineering of Chinese hamster ovary cells towards reduced biosynthesis and accumulation of novel growth inhibitors in fed-batch cultures
  123. Does childhood experience of attention-deficit hyperactivity disorder symptoms increase sleep/wake cycle disturbances as measured with actigraphy in adult patients with bipolar disorder?
  124. Light Therapy in Mood Disorders: A Brief History with Physiological Insights
  125. Bright light therapy improved sleep disturbances in a patient with dementia with Lewy bodies
  126. Bright Light as a Personalized Precision Treatment of Mood Disorders
  127. Which actigraphic variables optimally characterize the sleep-wake cycle of individuals with bipolar disorders?
  128. In Vivo Near-Infrared Fluorescence Imaging of Atherosclerosis Using Local Delivery of Novel Targeted Molecular Probes
  129. Environment risk factors have different impact on bipolar and psychotic disorders: an analysis of MHGP survey
  130. Quality of life and cost of strategies of two chemotherapy lines in metastatic colorectal cancer: results of the FFCD 2000-05 trial
  131. Two Manic Episodes Related to a Levetiracetam-Based Treatment in a 34-Year-Old Female Patient
  132. Bright Light Therapy in the Morning or at Mid-Day in the Treatment of Non-Seasonal Bipolar Depressive Episodes (LuBi): Study Protocol for a Dose Research Phase I / II Trial
  133. The Plastic Adaptation to Pathology in Psychiatry. Are Patients with Psychiatric Disorders Pathological Experts?
  134. Clock Genes and Light Signaling Alterations in Bipolar Disorder: When the Biological Clock Is Off
  135. Vitamin D5 in Arabidopsis thaliana
  136. Clinical characteristics of obstructive sleep apnea in bipolar disorders.
  137. Aux frontières de la sémiologie psychiatrique !
  138. Sleep and circadian rhythms as possible trait markers of suicide attempt in bipolar disorders: an actigraphy study
  139. More comprehensive models are needed to understand how relative amplitude might affect wellbeing and risk of mood disorders
  140. Lithium effects on serine-threonine kinases activity: High throughput kinomic profiling of lymphoblastoid cell lines from excellent-responders and non-responders bipolar patients
  141. Determination of sets of covariating gene expression using graph analysis on pairwise expression ratios
  142. The neurobiology of adaptation to seasons: Relevance and correlations in bipolar disorders
  143. Influence of comorbid alcohol use disorders on the clinical patterns of major depressive disorder: A general population-based study
  144. Metabolic syndrome and actigraphy measures of sleep and circadian rhythms in bipolar disorders during remission
  145. The Impact of Transcranial Direct Current Stimulation (tDCS) on Bipolar Depression, Mania, and Euthymia: a Systematic Review of Preliminary Data
  146. Prevalence and predictors of no lifetime utilization of mental health treatment among people with mental disorders in France: findings from the ‘Mental Health in General Population’ (MHGP) survey
  147. Increased prevalence of anxiety disorders in third-generation migrants in comparison to natives and to first-generation migrants
  148. Light treatment in depression: an antique treatment with new insights
  149. Sociodemographic and clinical correlates of psychotic symptoms in the general population: Findings from the MHGP survey
  150. L’application DICOSEMIOPSY ©  : un lexique de sémiologie psychiatrique illustré
  151. A study in the general population about sadness to disentangle the continuum from well-being to depressive disorders
  152. Insomnia and hypersomnia in major depressive episode: Prevalence, sociodemographic characteristics and psychiatric comorbidity in a population-based study
  153. A latent class analysis of psychotic symptoms in the general population
  154. Childhood trauma, dimensions of psychopathology and the clinical expression of bipolar disorders: A pathway analysis
  155. Irritable temperament and lifetime psychotic symptoms as predictors of anxiety symptoms in bipolar disorder
  156. Outcomes for bipolar patients assessed in the French expert center network: A 2-year follow-up observational study (FondaMental Advanced Centers of Expertise for Bipolar Disorder [FACE-BD])
  157. Transcranial direct-current stimulation (tDCS) for bipolar depression: A systematic review and meta-analysis
  158. Very early hallucinatory experiences: a school‐based study
  159. La sémiologie motrice en psychiatrie : une dimension oubliée !
  160. Les maladies neurologiques à expression psychiatrique : importance de l’examen neurologique
  161. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort
  162. Modifiable and non-modifiable factors associated with functional impairment during the inter-episodic periods of bipolar disorder
  163. Alcohol Use Disorders and Immigration up to the Third Generation in France: Findings from a 39,617-Subject Survey in the General Population
  164. Lithium response in bipolar disorder: No difference in GADL1 gene expression between cell lines from excellent-responders and non-responders
  165. Prodrome or risk syndrome: what’s in a name?
  166. Prevalence and clinical severity of mood disorders among first-, second- and third-generation migrants
  167. Residual depressive symptoms, sleep disturbance and perceived cognitive impairment as determinants of functioning in patients with bipolar disorder
  168. Lithium response in bipolar disorders and core clock genes expression
  169. Cross-validation of clinical characteristics and treatment patterns associated with phenotypes for lithium response defined by the Alda scale
  170. Childhood trauma and mixed episodes are associated with poor response to lithium in bipolar disorders
  171. Influence of lithium on sleep and chronotypes in remitted patients with bipolar disorder
  172. The RANZCP mood disorders guidelines: An easy step-by-step toolbox for daily practice
  173. Comment caractériser et traiter les plaintes de sommeil dans les troubles bipolaires ?
  174. Clinical factors associated with lithium response in bipolar disorders
  175. Circadian genes and lithium response in bipolar disorders: associations with PPARGC1A (PGC-1α) and RORA
  176. Does baclofen have antidepressant qualities?
  177. Factors Affecting the Agreement Between Emergency Psychiatrists and General Practitioners Regarding Involuntary Psychiatric Hospitalizations
  178. Lithium and suicide prevention in bipolar disorder
  179. Le boucher du Prince Wen-houei. De l’art médical du recueil sémiologique valide en psychiatrie
  180. Encéphalopathie mitochondriale neuro-gastro-intestinale (MNGIE) : quand et comment l’évoquer devant une anorexie mentale atypique ?
  181. How Anti-NMDAR Encephalitis Sheds Light on the Mechanisms Underlying Catatonia: The Neural Excitatory/Inhibitory Imbalance Model
  182. Seasonal Influence on Mass Shootings
  183. De « Psychose maniaco-dépressive » à « Troubles bipolaires » : une histoire des représentations sociales et de la stigmatisation en rapport avec la nosographie
  184. Psychiatrie du sujet âgé en milieu pénitentiaire
  185. Course of residual symptoms according to the duration of euthymia in remitted bipolar patients
  186. Lithium and bipolar disorder: Impacts from molecular to behavioural circadian rhythms
  187. Bipolar Disorder: The Role of the Kynurenine and Melatonergic Pathways
  188. Extreme sensory processing patterns and their relation with clinical conditions among individuals with major affective disorders
  189. The bidirectional relation between emotional reactivity and sleep: From disruption to recovery.
  190. Luminothérapie et épisodes dépressifs saisonniers du trouble bipolaire
  191. Effet des saisons sur la sémiologie des troubles bipolaires
  192. La sémiologie psychiatrique éclairée par les neurosciences
  193. Saisons, rythmes circadiens, sommeil et vulnérabilité aux conduites suicidaires
  194. Keep calm: Psychiatric disorders are organic! The power of words in medicine
  195. Catatonia and cannabis withdrawal: A case report
  196. Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends
  197. Melatonin in Bipolar Disorders
  198. Le jardinier et le botaniste. Proposition d’une organisation minimale de la sémiologie psychiatrique pour l’étudiant en médecine
  199. Genetic association study of circadian genes with seasonal pattern in bipolar disorders
  200. Syndrome catatonique précoce et encéphalite à auto-anticorps antirécepteurs-NMDA : une mise au point
  201. Individuals With Bipolar Disorder and Their Relationship With the Criminal Justice System: A Critical Review
  202. Effects of Clozapine on Perceptual Abnormalities and Sensory Gating
  203. Sleep- and circadian rhythm–associated pathways as therapeutic targets in bipolar disorder
  204. Reply: Sleep in Patients with Remitted Bipolar Disorders: Analyses stratified on actigraphy devices, age and gender
  205. Prédire le trouble bipolaire : que pouvons-nous apprendre des études prospectives de cohortes ?
  206. Trouble bipolaire de l’humeur : effet des sels de lithium sur les rythmes circadiens
  207. Links between sleep and body mass index in bipolar disorders: An exploratory study
  208. Voyage et troubles psychotiques : clinique et recommandations pratiques
  209. Les anomalies du sommeil peuvent-elles participer au risque cardio-vasculaire des troubles bipolaires ?
  210. Sleep in patients with remitted bipolar disorders: a meta-analysis of actigraphy studies
  211. EEG neurofeedback treatments in children with ADHD: an updated meta-analysis of randomized controlled trials
  212. Sciences et psychiatrie
  213. Seasonality and bipolar disorder: A systematic review, from admission rates to seasonality of symptoms
  214. The arcuate fasciculus in auditory-verbal hallucinations: A meta-analysis of diffusion-tensor-imaging studies
  215. Brain changes in early-onset bipolar and unipolar depressive disorders: a systematic review in children and adolescents
  216. Le trouble bipolaire chez l’enfant et l’adolescent : un diagnostic difficile
  217. Traitement du trouble bipolaire en phase maniaque : synthèse critique des recommandations internationales
  218. Baclofen-Induced Manic Symptoms: Case Report and Systematic Review
  219. État actuel de la formation des médecins généralistes à la psychiatrie et à la santé mentale en France
  220. Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response
  221. Sleep in remitted bipolar disorder: A naturalistic case-control study using actigraphy
  222. Correlations between objective and subjective sleep and circadian markers in remitted patients with bipolar disorder
  223. Somatotopy and bodily hallucinations
  224. Antipsychotics Management in Addictive Disorders
  225. État actuel de la formation des médecins généralistes à la psychiatrie et à la santé mentale en France
  226. Can the response to mood stabilizers be predicted in bipolar disorder
  227. An ASMT variant associated with bipolar disorder influences sleep and circadian rhythms: a pilot study
  228. Épisodes dépressifs mixtes : clinique et biomarqueurs neurophysiologiques
  229. Personnalité normale et pathologique au cours du vieillissement : diagnostic, évolution, et prise en charge
  230. Kleine-Levin syndrome and bipolar disorder: a differential diagnosis of recurrent and resistant depression
  231. Reconsideration of bipolar disorder as a developmental disorder: Importance of the time of onset
  232. Bipolar Disorder with Seasonal Pattern: Clinical Characteristics and Gender Influences
  233. Chronotypes of Bipolar Patients in Remission: Validation of the French Version of the Circadian Type Inventory in the FACE-BD Sample
  234. Gestion des traitements de substitution aux opiacés lorsqu’un antalgique est indiqué
  235. Corrélats anatomofonctionnels du syndrome d’Ekbom
  236. Gene X Environment Interactions in Schizophrenia and Bipolar Disorder: Evidence from Neuroimaging
  237. Abstinence dans l’alcoolodépendance : approche critique et actualisée des recommandations nationales de 2001
  238. Aripiprazole for Treating Cannabis-Induced Psychotic Symptoms in Ultrahigh-Risk Individuals
  239. Génétique des hallucinations : des voix pas sans gène !
  240. Combination Therapy for Manic Phases: A Critical Review of a Common Practice
  241. Une entité clinique aux implications thérapeutiques majeures : le trouble bipolaire à début précoce
  242. Fibromyalgie et psychiatrie : 35 ans plus tard… Quoi de neuf ?
  243. Efficacy of Aripiprazole in Comorbid Addiction in Bipolar Disorder
  244. Catatonia and Alcohol Withdrawal: A Complex and Underestimated Syndrome
  245. Génétique des hallucinations : des voix pas sans gène !
  246. Use of Aripiprazole in Treatment of Cannabis Dependence in a Patient Presenting With Borderline Personality Disorder
  247. Shared vulnerability between seizures and psychosis in cocaine addiction?